Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 8/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.52 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303680 | 0.88 | OPRM1 (0.47) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL987907 | 0.87 | LMNA (0.47) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL5166279 | 0.87 | OPRM1 (0.51) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL873080 | 0.84 | OPRM1 (0.43) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL9486794 | 0.84 | TSHR (0.47) | SMN1; SMN2GAAL3MBTL1 | |
| SCHEMBL14967201 | 0.83 | TSHR (0.49) | SMN1; SMN2L3MBTL1 | |
| SCHEMBL7384877 | 0.83 | OPRM1 (0.51) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL14967672 | 0.83 | ALDH1A1 (0.43) | SMN1; SMN2GAAGLAL3MBTL1 | |
| SCHEMBL14967285 | 0.82 | TSHR (0.50) | SMN1; SMN2L3MBTL1 | |
| SCHEMBL15194500 | 0.81 | MAPT (0.41) | OPRM1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024655-A1 | UREA COMPOSITIONS AND METHODS OF USE | BALANCE LYTES, LLC (US) | 2025-01-30 | — | — | WO | claimed |
| US-20240182643-A1 | RIGID NON-ISOCYANATE POLYURETHANE FOAM AND PREPARATION METHOD THEREFOR | WUHAN INSTITUTE OF TECHNOLOGY (CN) | 2024-06-06 | — | — | US | claimed |
| EP-3033371-B2 | CURABLE COMPOSITION COMPRISING 2,5-BISAMINOMETHYLFURANE | BASF SE (DE) | 2021-09-22 | — | — | EP | claimed |
| EP-3033371-B1 | USE OF 2,5-BISAMINOMETHYLFURANE AS CURING AGENT FOR EPOXY RESINS | BASF SE (DE) | 2019-11-06 | — | — | EP | claimed |
| CN-106666631-A | Strawberry flavor food additive | 王俊 | 2017-05-17 | — | — | CN | claimed |
| EP-2817349-B1 | BLENDS FOR COMPOSITES | BASF SE (DE) | 2017-04-19 | — | — | EP | claimed |
| US-20160185896-A1 | USE OF 2,5-BIS(AMINOMETHYL)FURAN AS A HARDENER FOR EPOXY RESINS | BASF SE (DE) | 2016-06-30 | — | — | US | claimed |
| US-20140213697-A1 | 2,2',6,6'-TETRAMETHYL-4,4'-METHYLENEBIS(CYCLOHEXYLAMINE) AS HARDENER FOR EPOXY RESINS | BASF SE (DE) | 2014-07-31 | — | — | US | claimed |
| CN-101535380-B | Metal coordinating and film-forming materials | BASF CORP | 2012-11-28 | — | — | CN | claimed |
| CN-101528795-B | Metal coordinating and film-forming materials | BASF CORP | 2012-02-29 | — | — | CN | claimed |
| US-7772334-B2 | Crosslinker of reactive functional groups and nonionic metal coordinating structure-containing alkyl or aromatic compound | BASF COATINGS GMBH (DE) | 2010-08-10 | — | — | US | claimed |
| US-7759436-B2 | Film-former of resin with nonionic metal coordinating structure and crosslinker-reactive group | BASF COATINGS GMBH (DE) | 2010-07-20 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| CN-101528795-A | Metal coordinating and film-forming materials | BASF CORP (US) | 2009-09-09 | — | — | CN | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| WO-1983000334-A1 | PHENYLALKYLOXIRANE CARBOXYLIC ACIDS, PREPARATION AND THERAPEUTICAL USE | KOHL, BERNHARD | 1983-02-03 | — | — | WO | disclosed |
| US-4337267-A | HYPOKETONEMIC, HYPOGLYCEMIC, ANTIDIABETIC | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1982-06-29 | — | — | US | disclosed |
| US-4324796-A | HYPOGLYCEMIC AGENTS, HYPOKETONEMIC AGENTS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1982-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | OPRM1 4061/4885OPRD1 2260/4885OPRK1 3013/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | OPRM1 269/4885OPRD1 421/4885OPRK1 684/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | OPRM1 92/4885OPRD1 126/4885OPRK1 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.